News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Halozyme Therapeutics, Inc. (HTI) Selects Mentus, Inc. For National Product Launch



10/19/2005 5:10:44 PM

SAN DIEGO, March 30 /PRNewswire/ -- Mentus, a leading life sciences marketing and communications firm, today announced it has been selected by Halozyme Therapeutics, Inc. to provide strategic public relations and marketing communications services in support of its robust product pipeline. Halozyme is a therapeutically driven biopharmaceutical company focused on the development and commercialization of recombinant human enzymes.

"Mentus' intimate knowledge of life sciences, particularly devices and biopharmaceuticals, will be invaluable as we begin the next phase of our growth cycle and enter production of our first product," said Mark Wilson, Halozyme's Vice President of Business Development. "With its 24 years in biotech, Mentus instinctively knows our IP, our audiences and our objectives to implement the strategies to get us where we want to be."

As Halozyme's agency of record, Mentus will execute a comprehensive marketing campaign; including developing a new corporate identity and collateral, as well as conducting advocacy outreach, media relations and product launch activities.

"Mentus' life science expertise, along with its award-winning branding, marketing and public relations programs, makes it the perfect partner to help Halozyme Therapeutics transition from development stage to a product-driven company." says Guy Iannuzzi, President of Mentus. "We look forward to a long and rewarding relationship."

About Halozyme Therapeutics

Halozyme is a therapeutically driven biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the infertility, ophthalmology and oncology communities. The company's broad product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's lead products offer a safe and pure alternative to existing slaughterhouse-derived extracts that carry high risks of animal pathogen contamination and immunogenicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to significantly impact the quality of medicine while creating significant shareholder value.

About Mentus Life Science

With over 24 years of experience, Mentus Life Science is a leading integrated marketing communications firm specializing in the life sciences industries, including medical device & diagnostics, biotechnology, pharmaceuticals and consumer healthcare. Headquartered in San Diego, the firm serves clients throughout the U.S. and globally ranging from start-up companies to Fortune 500. For more information, visit http://www.mentus.com/.

Mentus Life Science

CONTACT: Kathy Witz Sweeney, ext. 212, kwitz@mentus.com, or MeganSwanland Riggs, ext. 215, megan@mentus.com, both of Mentus, +1-858-455-5500


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES